Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction

Overview of attention for article published in World Journal of Surgical Oncology, January 2012

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (60th percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 18,102 followers.

◈ Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction: Backg... http://t.co/RzcJ9rWs ◈

Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction http://t.co/1KOXQaP4

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.